NEW YORK (GenomeWeb News) — Phenomenex today said it will distribute Beckman Coulter’s protein-partitioning and depletion product in North America and in Europe.
Under the agreement, Torrance, Calif.-based Phenomenex will market and sell Beckman’s ProteomeLab IgY-12. The IgY is based on avian-generated antibodies and “delivers an enriched proteome that includes medium and low-abundance proteins that are of interest to biomarker research,” Phenomenex said.
Michael McGinley, Phenomenex’s biochromatography product manager, said the IgY will “fit well” with the company’s proteomics offerings for protein and peptide separation.
Financial terms of the agreement were not released.